The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck
Authors:
- Christopher S. HollenbeakCHChristopher S. Hollenbeak
- Brendan C. StackBSBrendan C. Stack
Open Access
Abstract
BACKGROUND Although surgery and radiation are effective treatments of regional lymphatics for classification N0 head and neck squamous cell carcinoma (HNSCC) patients, both have morbidities that could be avoided in approximately 70% of patients without lymph node disease with better diagnostic information. 18‐F fluoro‐2‐deoxyglucose positron emission tomography (FDG‐PET) has shown promise in detecting subclinical lymph node disease, but its cost and availability have limited its use. Here, we sought to determine whether the use of FDG‐PET was cost‐effective as part of a treatment strategy for classification N0 HNSCC patients. METHODS The cost‐effectiveness of proceeding from classification of N0 by computed tomography to a PET scan was estimated using standard methods of economic evaluation. Costs were for a large, Midwestern university medical center. Probabilities were computed from a review of the literature. Utilities were obtained by a time‐tradeoff method, and life expectancy was estimated using the Surveillance, Epidemiology, and End Results database. Outcomes measures were cost per year of life saved and cost per quality‐adjusted life‐year. RESULTS Modified radical neck dissection was associated with the lowest morbidity (utility [u] = 0.93), and radical neck dissection plus radiation was associated with the highest (u = 0.68). Life expectancy was estimated to be 5.9 and 11.5 years for patients with and without lymph node disease, respectively. The incremental cost‐effectiveness ratio for the PET strategy was $8718 per year of life saved, or $2505 per quality‐adjusted life‐year. CONCLUSIONS A diagnostic and treatment strategy that proceeds from classification of N0 to a PET scan is cost‐effective. Prospective studies that evaluate this strategy are important to assure that these simulation results are realized in clinical practice. Cancer 2001;92:2341–8. © 2001 American Cancer Society.Keywords
This publication has 29 references indexed in Scilit:
- Pathology of the N0 neckBritish Journal of Oral and Maxillofacial Surgery, 1999
- Cost-effectiveness of PET imaging in clinical oncologyNuclear Medicine and Biology, 1996
- Critical Appraisal of Watchful Waiting Policy in the Management of NO Neck of Advanced Laryngeal CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1996
- The Role of FDG-PET in the Preoperative Assessment of N-Staging in Head and Neck CancerActa Oto-Laryngologica, 1996
- A comparative diagnostic study of head and neck nodal metastases using positron emission tomographyThe Laryngoscope, 1995
- Floor of Mouth Carcinoma: The Management of the Clinically Negative NeckJAMA Otolaryngology–Head & Neck Surgery, 1995
- Assessment of quality of life in head and neck cancer patientsHead & Neck, 1993
- Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathyThe Laryngoscope, 1992
- A convenient approximation of life expectancy (the “DEALE”)The American Journal of Medicine, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958